Haemtech Biopharma Services
News/Events

Haematologic Technologies Adds a High Resolution Mass Spectrometry Lab

Expanded Capabilities add to HTI’s Growing Large Molecule Bioanalysis Services Business September 30th, 2020 Essex Junction, VT –Haematologic Technologies (HTI), a leading protein chemistry company providing products and analytical services supporting the research, development, and commercialization of large molecule biotherapeutics,

Read more ›

Haematologic Technologies Appoints Steve Pemberton as Vice President of Commercial Development

August 31th , 2020 Essex Junction, VT – Haematologic Technologies (HTI), a leading protein chemistry company providing products and analytical services supporting the research, development, and commercialization of large molecule biotherapeutics, today announced the expansion of the Senior Leadership Team

Read more ›

Haematologic Technologies Announces Jean Pineault as President and Chief Executive Officer

June 1, 2020, Essex Junction, VT – Haematologic Technologies (HTI), a leading provider of products and analytical services supporting the research, development, and commercialization of large molecule biotherapeutics, today announced that Jean Pineault has been appointed President & CEO. Jean

Read more ›

Edgewater Capital Partners to Acquire Haematologic Technologies

Joint News Release HTI Media Contact:Robert Myers, VP of Business DevelopmentTel.: (802) 878-1777Email: [email protected] Edgewater Media Contact:Robert Girton, PartnerTel.: (216) 292-3858Email: [email protected] Edgewater Capital Partners to Acquire Haematologic Technologies Essex Junction, VT and Cleveland, OH, October 11, 2019 – Edgewater

Read more ›

Haemtech to present on Thrombin Generation Assay applications

Dr. Ryan Dorfman, VP of Operations, will present on Thrombin Generation Assay (TGA) applications at the 2nd Hemophilia Drug Development Summit in Boston, MA on August 21st. During the presentation, Dr. Dorfman will discuss the basics of the thrombin generation

Read more ›